-
Signature
-
/s/ Mary Wright, as Attorney-in-Fact
-
Issuer symbol
-
INGN
-
Transactions as of
-
01 Sep 2025
-
Transactions value $
-
$11,985
-
Form type
-
4
-
Date filed
-
03 Sep 2025, 17:01
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Smith Kevin Raymond Merrill |
CEO and President, Director |
C/O INOGEN, INC., 859 WARD DRIVE, GOLETA |
/s/ Mary Wright, as Attorney-in-Fact |
2025-09-03 |
0001802639 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
INGN |
Common Stock |
Award |
$12K |
+1.5K |
+2.13% |
$7.99 |
71.8K |
01 Sep 2025 |
Direct |
F1 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: